- Home
- RGR vs PLRX Comparison
RGR vs PLRX Comparison
Compare RGR & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- PLRX
- Stock Information
- Founded
- RGR 1949
- PLRX 2015
- Country
- RGR United States
- PLRX United States
- Employees
- RGR N/A
- PLRX N/A
- Industry
- RGR Ordnance And Accessories
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- PLRX Health Care
- Exchange
- RGR Nasdaq
- PLRX Nasdaq
- Market Cap
- RGR 553.4M
- PLRX 89.0M
- IPO Year
- RGR N/A
- PLRX 2020
- Fundamental
- Price
- RGR $39.22
- PLRX $1.46
- Analyst Decision
- RGR
- PLRX Hold
- Analyst Count
- RGR 0
- PLRX 10
- Target Price
- RGR N/A
- PLRX $3.93
- AVG Volume (30 Days)
- RGR 185.5K
- PLRX 692.5K
- Earning Date
- RGR 10-29-2025
- PLRX 11-06-2025
- Dividend Yield
- RGR 1.78%
- PLRX N/A
- EPS Growth
- RGR N/A
- PLRX N/A
- EPS
- RGR 0.35
- PLRX N/A
- Revenue
- RGR $536,291,000.00
- PLRX N/A
- Revenue This Year
- RGR N/A
- PLRX N/A
- Revenue Next Year
- RGR $3.39
- PLRX N/A
- P/E Ratio
- RGR $113.66
- PLRX N/A
- Revenue Growth
- RGR 3.31
- PLRX N/A
- 52 Week Low
- RGR $31.64
- PLRX $1.10
- 52 Week High
- RGR $42.76
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- RGR 76.94
- PLRX 40.86
- Support Level
- RGR $34.42
- PLRX $1.66
- Resistance Level
- RGR $39.97
- PLRX $1.85
- Average True Range (ATR)
- RGR 0.94
- PLRX 0.12
- MACD
- RGR 0.48
- PLRX -0.03
- Stochastic Oscillator
- RGR 86.96
- PLRX 2.27
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.